Physician profile
Ryan Nicholas Chan
NPI 1093184988
$8,608.70
in general payments reported to CMS, 2019-2025
16 companies · $3,917 in 2025
The $3,917 reported for 2025 was more than what 98% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $512 · 2022: $279 · 2023: $647 · 2024: $3,252 · 2025: $3,917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,907 · Travel and Lodging: $2,910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,907.12 |
| Travel and Lodging | $2,910.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,266.46 | 2024-2025 | Impella |
| Zimmer Biomet Holdings, INC. | $1,307.39 | 2025 | Venapax |
| Medtronic, INC. | $1,183.06 | 2021-2025 | Progrip, Endurant Iis |
| Baxter Healthcare | $810.35 | 2022-2025 | Preveleak, Floseal, Tissue Guard |
| W. L. Gore & Associates, INC. | $525.11 | 2024-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft, Gore Tag Conformable Thoracic Endoprosthesis |
| Getinge USA Sales, LLC | $498.01 | 2021-2024 | Vasoview Hemopro 2 |
| Edwards Lifesciences Corporation | $425.42 | 2024-2025 | Mitris Resilia Mitral Valve |
| Atricure, INC. | $348.70 | 2023-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System |
| Abbott Laboratories | $312.95 | 2021-2024 | Epic |
| Kestra Medical Technology Services, INC. | $299.34 | 2024-2025 | Assure Wcd |
| Angiodynamics, INC. | $204.67 | 2024-2025 | Angiovac |
| Davol INC. | $146.45 | 2021 | |
| Smith+Nephew, INC. | $139.60 | 2022-2023 | Renasys Go V2 Home, Pico |
| Regeneron Healthcare Solutions, INC. | $76.16 | 2022-2023 | Dupixent |
| Philips North America LLC | $43.17 | 2024 | (Bs2) Lm Undivided |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21.86 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.